Current Biomarkers for Carotid Artery Stenosis: A Comprehensive Review of the Literature

Overview

Journal Metabolites

Publisher MDPI

Date 2023 Aug 25

PMID 37623863

Authors

Hamzah Khan

Farah Shaikh

Muzammil H Syed

Muhammad Mamdani

Gustavo Saposnik

Mohammad Qadura

Affiliations

Soon will be listed here.

Abstract

Carotid artery stenosis (CAS), an atherosclerotic disease of the carotid artery, is one of the leading causes of transient ischemic attacks (TIA) and cerebrovascular attacks (CVA). The atherogenic process of CAS affects a wide range of physiological processes, such as inflammation, endothelial cell function, smooth muscle cell migration and many more. The current gold-standard test for CAS is Doppler ultrasound; however, there is yet to be determined a strong, clinically validated biomarker in the blood that can diagnose patients with CAS and/or predict adverse outcomes in such patients. In this comprehensive literature review, we evaluated all of the current research on plasma and serum proteins that are current contenders for biomarkers for CAS. In this literature review, 36 proteins found as potential biomarkers for CAS were categorized in to the following nine categories based on protein function: (1) Inflammation and Immunity, (2) Lipid Metabolism, (3) Haemostasis, (4) Cardiovascular Markers, (5) Markers of Kidney Function, (6) Bone Health, (7) Cellular Structure, (8) Growth Factors, and (9) Hormones. This literature review is the most up-to-date and current comprehensive review of research on biomarkers of CAS, and the only review that demonstrated the several pathways that contribute to the initiation and progression of the disease. With this review, future studies can determine if any new markers, or a panel of the proteins explored in this study, may be contenders as diagnostic or prognostic markers for CAS.

Citing Articles

Assessment of Inflammatory and Oxidative Stress Biomarkers for Predicting of Patients with Asymptomatic Carotid Artery Stenosis.

Karaduman A, Ilgin S, Aykac O, Yesilkaya M, Levent S, Ozdemir A J Clin Med. 2025; 14(3).

PMID: 39941424 PMC: 11818673. DOI: 10.3390/jcm14030755.

Identification of symptomatic carotid artery plaque: a predictive model combining angiography with optical coherence tomography.

Zhuo J, Wang L, Li R, Li Z, Zhang J, Xu Y Front Neurol. 2024; 15:1445227.

PMID: 39281411 PMC: 11392725. DOI: 10.3389/fneur.2024.1445227.

The impact of homocysteine on patients with diabetic nephropathy: a mendelian randomization study.

Wang B, Li H, Wang N, Li Y, Song Z, Chen Y Acta Diabetol. 2024; 62(1):123-130.

PMID: 39105808 DOI: 10.1007/s00592-024-02343-9.

Inflammatory Biomarkers to Predict Major Adverse Cardiovascular Events in Patients with Carotid Artery Stenosis.

Li B, Shaikh F, Zamzam A, Abdin R, Qadura M Medicina (Kaunas). 2024; 60(6).

PMID: 38929614 PMC: 11205582. DOI: 10.3390/medicina60060997.

Diagnostic and prognostic role of serum interleukin-6 and carotid ultrasonography to detect subclinical atherosclerosis in patients with RA and ANCA-associated vasculitis.

Popova V, Geneva-Popova M, Popova-Belova S, Doykov M, Valkanov S, Batalov Z Rheumatol Int. 2024; 44(7):1295-1303.

PMID: 38554194 DOI: 10.1007/s00296-024-05568-7.

References

Makarovic S, Makarovic Z, Steiner R, Mihaljevic I, Milas-Ahic J . Osteoprotegerin and Vascular Calcification: Clinical and Prognostic Relevance. Coll Antropol. 2016; 39(2):461-8. View

Shin W, Zabel B, Pachynski R . Mechanisms and Functions of Chemerin in Cancer: Potential Roles in Therapeutic Intervention. Front Immunol. 2018; 9:2772. PMC: 6283908. DOI: 10.3389/fimmu.2018.02772. View

Fatemi S, Acosta S, Zarrouk M, Engstrom G, Melander O, Gottsater A . Circulating Biomarkers Predict Symptomatic but Not Asymptomatic Carotid Artery Stenosis. Cerebrovasc Dis. 2022; 51(5):623-629. DOI: 10.1159/000523839. View

Kim H, Kim S, Han S, Rane P, Fox K, Qian Y . Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study. BMC Public Health. 2019; 19(1):1112. PMC: 6694551. DOI: 10.1186/s12889-019-7439-0. View

Sodek J, Ganss B, McKee M . Osteopontin. Crit Rev Oral Biol Med. 2000; 11(3):279-303. DOI: 10.1177/10454411000110030101. View

Mayer F, Binder C, Wagner O, Schillinger M, Minar E, Mlekusch W . Combined Effects of Inflammatory Status and Carotid Atherosclerosis: A 12-Year Follow-Up Study. Stroke. 2016; 47(12):2952-2958. DOI: 10.1161/STROKEAHA.116.013647. View

Wu M, Rementer C, Giachelli C . Vascular calcification: an update on mechanisms and challenges in treatment. Calcif Tissue Int. 2013; 93(4):365-73. PMC: 3714357. DOI: 10.1007/s00223-013-9712-z. View

Lee T, Cheng M, Shiao M, Lin C . Metabolomics study in severe extracranial carotid artery stenosis. BMC Neurol. 2019; 19(1):138. PMC: 6589885. DOI: 10.1186/s12883-019-1371-x. View

Ganguly P, Alam S . Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015; 14:6. PMC: 4326479. DOI: 10.1186/1475-2891-14-6. View

10.

Kong D, Kim Y, Kim M, Jang J, Lee S . Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer. Int J Mol Sci. 2018; 19(4). PMC: 5979609. DOI: 10.3390/ijms19041057. View

11.

Sandstedt J, Vargmar K, Bjorkman K, Ruetschi U, Bergstrom G, Mattsson Hulten L . COMP (Cartilage Oligomeric Matrix Protein) Neoepitope: A Novel Biomarker to Identify Symptomatic Carotid Stenosis. Arterioscler Thromb Vasc Biol. 2021; 41(3):1218-1228. PMC: 7901532. DOI: 10.1161/ATVBAHA.120.314720. View

12.

Byskov K, Boettger T, Ruehle P, Nielsen N, Etscheid M, Kanse S . Factor VII activating protease (FSAP) regulates the expression of inflammatory genes in vascular smooth muscle and endothelial cells. Atherosclerosis. 2017; 265:133-139. DOI: 10.1016/j.atherosclerosis.2017.08.029. View

13.

Mott M, Koroshetz W, Wright C . CREST-2: Identifying the Best Method of Stroke Prevention for Carotid Artery Stenosis: National Institute of Neurological Disorders and Stroke Organizational Update. Stroke. 2017; 48(5):e130-e131. PMC: 5467643. DOI: 10.1161/STROKEAHA.117.016051. View

14.

Berntsson J, Ostling G, Persson M, Smith J, Hedblad B, Engstrom G . Orosomucoid, Carotid Plaque, and Incidence of Stroke. Stroke. 2016; 47(7):1858-63. DOI: 10.1161/STROKEAHA.116.013374. View

15.

Alexopoulos N, Raggi P . Calcification in atherosclerosis. Nat Rev Cardiol. 2009; 6(11):681-8. DOI: 10.1038/nrcardio.2009.165. View

16.

Spiel A, Gilbert J, Jilma B . von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation. 2008; 117(11):1449-59. DOI: 10.1161/CIRCULATIONAHA.107.722827. View

17.

Bergeron N, P Phan B, Ding Y, Fong A, Krauss R . Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk. Circulation. 2015; 132(17):1648-66. DOI: 10.1161/CIRCULATIONAHA.115.016080. View

18.

Kuyumcu A . The relationship between nesfatin-1 and carotid artery stenosis. Scand Cardiovasc J. 2019; 52(6):328-334. DOI: 10.1080/14017431.2018.1547840. View

19.

Wysocka A, Cybulski M, Wysokinski A, Berbec H, Stazka J, Zapolski T . Paraoxonase 1 Activity, Polymorphism and Atherosclerosis Risk Factors in Patients Undergoing Coronary Artery Surgery. J Clin Med. 2019; 8(4). PMC: 6518099. DOI: 10.3390/jcm8040441. View

20.

Tatzber F, Rabl H, Koriska K, Erhart U, Puhl H, Waeg G . Elevated serum neopterin levels in atherosclerosis. Atherosclerosis. 1991; 89(2-3):203-8. DOI: 10.1016/0021-9150(91)90061-7. View